PMID: 6966901Jun 1, 1980Paper

Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia

Annals of Internal Medicine
D J WinstonL S Young

Abstract

Intravenous trimethoprim-sulfamethoxazole therapy was evaluated in 11 consecutive patients with documented Pneumocystis carinii pneumonia and the results compared to those from previously published studies of trimethoprim-sulfamethoxazole therapy for P. carinii pneumonia. Although six patients needed mechanical ventilation, intravenous therapy was successful in seven of 11 patients (64%), and seven of nine patients (78%) receiving 4 or more days of intravenous trimethoprim-sulfamethoxazole therapy were cured. Side effects occurred in two patients (skin rash in one, nausea and vomiting in one). A review of 80 reported cases of confirmed P. carinii pneumonia initially treated with trimethoprim-sulfamethoxazole alone revealed response rates of 67.5% in all treated patients and 85.5% in patients treated for 9 or more days. The clinical response was similar in adults (63.2%) and children (68.9%). Side effects were noted in only 11 of 80 patients (13.8%). Compared to pentamidine, trimethoprim-sulfamethoxazole has a narrower toxic-therapeutic ratio and should be preferred treatment for P. carinii pneumonia in adults as well as children.

Citations

Mar 1, 1991·Journal of Clinical Immunology·A CarrR Penny
Feb 1, 1996·Molecular and Biochemical Parasitology·P RecheL M Ruiz-Perez
Jan 1, 1984·Diagnostic Microbiology and Infectious Disease·P D Walzer, L S Young
Feb 16, 1985·Lancet
Apr 12, 1986·Lancet·F J BowdenC R Lucas
Jan 1, 1988·Antimicrobial Agents and Chemotherapy·P D WalzerM T Cushion
Aug 1, 1988·Antimicrobial Agents and Chemotherapy·A B ClarksonC Rosenberg
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Olga SenkovichDebasish Chattopadhyay
Aug 22, 1981·British Medical Journal·L S Hill, P R Dean
May 29, 1982·British Medical Journal·G R WilliamsW C Love
Mar 19, 1983·British Medical Journal·D C Flenley
Apr 2, 1983·British Medical Journal·J Cooke, C C Bailey
May 7, 1988·British Medical Journal·D W Ryan, J Oyston
Jan 1, 1983·Postgraduate Medical Journal·H C Thomas
Sep 1, 1988·Postgraduate Medical Journal·R J McGonigleD Adu
Jun 1, 1985·Der Internist·A SzabadosF Deinhardt
Jun 1, 1990·The American Review of Respiratory Disease·J F Murray, J Mills
Jun 10, 2014·Annals of Intensive Care·Glen R Brown
Sep 1, 1983·Issues in Comprehensive Pediatric Nursing·K Ruccione
Jul 1, 1991·The Annals of Thoracic Surgery·H SaigenjiJ G Copeland
Nov 3, 2009·Paediatric Respiratory Reviews·Vasilios PyrgosThomas J Walsh
Mar 1, 1984·The American Journal of Medicine·B Wong
Mar 1, 1984·The American Journal of Medicine·H W Haverkos
Dec 1, 1987·Australian and New Zealand Journal of Medicine·P G GibsonD A Cooper
Mar 1, 1983·La Revue de médecine interne·C MayaudJ Roland
Dec 1, 1991·Annals of Emergency Medicine·D A Talan, C A Kennedy
Aug 17, 2006·The Annals of Pharmacotherapy·Daren LinMichael J Rieder
Sep 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J A Fishman
Aug 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S J MuñozW C Maddrey
Oct 27, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Jan 1, 1984·Annals of the New York Academy of Sciences·J W Gold, D Armstrong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.